FierceBiotech

Medtronic, BD to collaborate on diabetes infusion set featuring enhanced insulin delivery

Medtronic ($MDT) will commercialize Becton Dickinson's ($BDX) insulin pump infusion set with FlowSmart technology, the companies announced at the annual meeting of ...
FierceBiotech

FDA clears BD insulin infusion set developed with diabetes patient advocacy groups

Becton Dickinson ($BDX) worked with diabetes patient advocate groups to develop its latest insulin infusion set, which is designed for improved insulin flow with ...
Yahoo Finance

BD expands Class I recall to cover 15 more Alaris pump infusion sets

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD has expanded a Class I Alaris recall to cover 15 ...
Yahoo Finance

BD (BDX) Receives FDA Nod to Address Critical Infusion Needs

Becton, Dickinson and Company BDX, popularly known as BD, recently received the FDA’s 510(k) clearance for its updated BD Alaris Infusion System. This is expected to enable both remediation and a ...
Nasdaq

BD Provides Update on Voluntary Recalls of Alaris(TM) Pump Module Model 8100 and Certain Alaris(TM) Pump Infusion Sets

FRANKLIN LAKES, N.J., July 18, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on two voluntary recalls ...
Healio

BD receives funding for insulin infusion therapy improvements

Please provide your email address to receive an email when new articles are posted on . BD will be entering into a new research partnership with JDRF to improve insulin infusion sets, according to a ...
USA Today

BD Provides Update on Voluntary Recall of Certain BD Alaris™ Pump Infusion Sets

FRANKLIN LAKES, N.J. (Sept. 12, 2025) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today expanded their Class I voluntary recall initiated in the ...